141 related articles for article (PubMed ID: 37499483)
1. Growth and dormancy control of myeloma cells by mesenchymal stem cells.
Mehdi SJ; Ghatak K; Ling W; Johnson SK; Epstein J; Nookaew I; Zangari M; Schinke C; Thanendrarajan S; van Rhee F; Yaccoby S
Leuk Res; 2023 Oct; 133():107355. PubMed ID: 37499483
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Mehdi SJ; Johnson SK; Epstein J; Zangari M; Qu P; Hoering A; van Rhee F; Schinke C; Thanendrarajan S; Barlogie B; Davies FE; Morgan GJ; Yaccoby S
Br J Haematol; 2019 Feb; 184(4):578-593. PubMed ID: 30408155
[TBL] [Abstract][Full Text] [Related]
3. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
Schinke C; Qu P; Mehdi SJ; Hoering A; Epstein J; Johnson SK; van Rhee F; Zangari M; Thanendrarajan S; Barlogie B; Davies FE; Yaccoby S; Morgan GJ
Clin Cancer Res; 2018 Jun; 24(12):2913-2919. PubMed ID: 29563136
[No Abstract] [Full Text] [Related]
4. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
5. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma.
Jin J; Cheng S; Wang Y; Wang T; Zeng D; Li Z; Li X; Wang J
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1258-1266. PubMed ID: 31769473
[TBL] [Abstract][Full Text] [Related]
6. [The effect of TNF-alpha on TAZ expression and osteogenic potential of mesenchymal stem cells from myeloma patients].
Li BZ; Shi MX; Li J; Ma J; Chen L; Chen B; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):5-9. PubMed ID: 19538860
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
10. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
11. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
12. Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
Wei XF; Chen QL; Fu Y; Zhang QK
J Cell Biochem; 2019 Apr; 120(4):6515-6527. PubMed ID: 30450775
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow NG2
Nobre AR; Risson E; Singh DK; Di Martino JS; Cheung JF; Wang J; Johnson J; Russnes HG; Bravo-Cordero JJ; Birbrair A; Naume B; Azhar M; Frenette PS; Aguirre-Ghiso JA
Nat Cancer; 2021 Mar; 2(3):327-339. PubMed ID: 34993493
[TBL] [Abstract][Full Text] [Related]
14. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.
Zhou YZ; Cheng Z; Wu Y; Wu QY; Liao XB; Zhao Y; Li JM; Zhou XM; Fu XM
J Cell Mol Med; 2019 Dec; 23(12):8233-8245. PubMed ID: 31583844
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta.
Roson-Burgo B; Sanchez-Guijo F; Del Cañizo C; De Las Rivas J
BMC Genomics; 2014 Oct; 15(1):910. PubMed ID: 25326687
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.
Kang H; Kim KH; Lim J; Kim YS; Heo J; Choi J; Jeong J; Kim Y; Kim SW; Oh YM; Choo MS; Son J; Kim SJ; Yoo HJ; Oh W; Choi SJ; Lee SW; Shin DM
Stem Cells Dev; 2015 Jul; 24(14):1658-71. PubMed ID: 25761906
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.
Li X; Ling W; Khan S; Yaccoby S
J Bone Miner Res; 2012 Aug; 27(8):1635-48. PubMed ID: 22460389
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
